SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Summary

The study will be conducted in adult patients with Chemotherapy-induced Peripheral Neuropathy (CIPN) that has been persistent for at least 3 months following completion of chemotherapy. A total of 60 patients will be enrolled in equal numbers of a placebo group and two different SON-080 dose groups. Treatment period will be 12 weeks long and patients will be followed-up for an additional 12 weeks.

Timeline

Start

2022-10-27

Primary completion

2024-03-17

Completion

2024-03-17

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of Enrollment”

Publications

• de Baat A, Trinh B, Ellingsgaard H, Donath MY. Physiological role of cytokines in the regulation of mammalian metabolism. Trends Immunol. 2023 Aug;44(8):613-627. doi: 10.1016/j.it.2023.06.002. Epub 2023 Jul 7.

Drugs

Indications